The Jesús Usón Minimally Invasive Surgery Centre (CCMIJU) is a Contract Research Organisation (CRO), an international reference centre in translational research, minimally invasive surgery, technological development and
specialised training. Strategic partner in public and private R&D Projects.
Regulatory framework
We have a Quality Assurance and Regulatory Framework department, designed to ensure the quality and integrity
of the data obtained in preclinical studies, carrying out audits in the different phases, audits of the facilities,
as well as audits of the internal processes related to the studies
1. TYPICAL PROCESS FLOW OF A GLP STUDY
2. GOOD LABORATORY PRACTICE CERTIFICATION
The centre is certified under the principles of Good Laboratory Practice (GLP) in the following areas of
certification:
- In vivo toxicity
- Toxicity in vitro
- Tolerance::
- Dermal
- Ocular
- Pharmacodynamics
- Test product administration and specimen procurement
- Biocompatibility of healthcare products
3. UNE-EN-ISO 9001:2015 CERTIFICATION
The CCMIJU has the AENOR UNE-EN-ISO 9001:2015 certification, which gives us optimal document management,
allowing us to identify and address the needs of our customers and implement strategies for continuous
improvement
4. ANIMAL WELFARE ETHICS COMMITTEE
The CCMIJU has its own Animal Experimentation Ethics Committee. It is accredited by the Regional Government
of Extremadura and recognised by the Ministry of Science, Innovation and Universities as an authorised
body for the evaluation of all kinds of projects in which experimental animals are used.
5. AAALAC ACCREDITATION
AAALAC International is a non-profit organization of internationally recognized prestige, dedicated to evaluating institutions that use animals for experimental and educational purposes. The aim of this accreditation is to ensure that these institutions adopt more humane practices and safeguard the welfare of the animals used in their activities. CCMIJU is currently actively working to obtain this accreditation in 2026.
6. CONSULTANCY
We offer a specialised consultancy service for the planning, design and execution of preclinical studies, focused
on ensuring product safety, scientific soundness and resource optimisation. Our multidisciplinary team
provides strategic support from the initial phase of development to the achievement of the scientific and
regulatory objectives of the project.
Facilities
ANIMAL HOUSING
- SURFACE AREA OF 3200 m2
- CAPACITY TO HOUSE SMALL AND LARGE ANIMALS
- TRANSGENIC AREA
- QUARANTINE, RECOVERY AND TREATMENT ROOMS
OPERATING THEATRES
- 8 SPECIALISED EXPERIMENTAL OPERATING THEATRES
- GENERAL ANAESTHESIA EQUIPMENT
- SPECIFIC EQUIPMENT FOR MINIMALLY INVASIVE SURGERY PROCEDURES:
- Laparoscopy
- Endoscopy
- Interventional radiology
- Microsurgery
- ROBOTIC PLATFORMS (DA VINCI XI, SYMANI AND VERSIUS)
- ADVANCED MEDICAL IMAGING EQUIPMENT:
- Half-arc fluoroscope
- Ultrasound scanner
- Resonancia magnética 3 Teslas (RMN)
- Digital radiography
- OCT (Ophthalmology and vascular)
- Laser speckle contrast analysis (LASCA)
- INSTRON 6800 FOR BIOMECHANICAL TESTING
- HIGH FIDELITY SIMULATED ROOMS AND HYBRID OPERATING THEATRE
- NECROPSY ROOM
- STERILISATION ROOM
SPECIALISED LABORATORIES
- MAGISTRAL FORMULATION
- CLINICAL ANALYSIS:
- Haematology, biochemistry, urinalysis, coagulation, specific biomarkers
- CLINICAL ANALYSIS:
- Equipment of molecular biology techniques and biomarkers: ELISAs, qPCR, flow cytometry, fluorescence microscopy
- Cell culture rooms
- CONFOCAL MICROSCOPY
- ASSISTED REPRODUCTION:
- Equipment for in vitro fertilisation (IVF), ICSI, vitrification and devitrification of gametes and embryos and a time lapse system to evaluate embryo development.
- MEDICAL PRINTING:
- Equipment for 3D printing: FDM, SLA, SLS
- Equipment for bioprinting and generation of scaffolds: micro-extrusion,
droplet, DLP, electrospinning - Equipment for manufacturing and characterisation of biomaterials: viscosimetry, rheometry, DMA, UV-Vis
- Proof of concept and analysis of bioprinted scaffolds and drug delivery
- Prototyping and improvement of bioprinting systems
- Prototyping for simulation and surgical planning
- Computational simulation of biomaterials
Preclinical studies
Our CRO specialised in IN VIVO preclinical studies, offers customised solutions for both regulatory (GLP) and non-regulatory projects, attending to your needs, from pilot studies and proof of concept to regulated studies, minimising the risks prior to the clinical phase.
IN VITRO
- CYTOTOXICITY
- CELL PROLIFERATION
- CELL METABOLISM
- IMMUNOMODULATION
- GENOTOXICITY
- CELL MIGRATION
IN VIVO
- TOXICITY
- Acute
- Chronic
- Subacute
- Systemic
- Repeated dose
- PHARMACOKINETICS
- LOCAL TOLERANCE
- EFFECTIVENESS
- DOSE
- BIOCOMPATIBILITY OF MEDICAL DEVICES
- VALIDATION OF SURGICAL DEVICES
ANIMAL SPECIES
- Rodents
- Lagomorphs
- Swine
- Sheep
- Canine
ROUTES OF ADMINISTRATION
- Oral
- Intravenous
- Intramuscular
- Subcutaneous
- Dermal
- Intraperitoneal
- Vaginal
- Rectal
- Surgical
Experimental models
IN VITRO

PRIMARY CULTURE CELL LINES FROM DIFFERENT TISSUES AND ANIMAL SPECIES

CELL LINES ESTABLISHED FOR DIFFERENT DISEASE MODELS
IN VIVO
UROLOGICAL MODELS
- Ureteral obstruction
- Ureteral stricture
- Bladder stone disease
CUTANEOUS CYCATRIZATION MODELS
- Full-thickness ulcers
- Partial-thickness ulcers
- Pressure ulcers
- Burn sores
MODELS OFTHALMOLOGY
- Corneal ulcers
- Ocular inflammation
- Dry keratoconjunctivitis
MICROCHIRURGICAL MODELS
- Ischaemia reperfusion
- Arterio-venous fistulas
- Secondary lymphoedema
CARDIOVASCULAR MODELS
- Biocompatibility of stents
- Device testing
- Acute myocardial infarction
- Heart failure – Chronic infarction
- Ventricular tachyarrhythmias
TRAUMATOLOGY AND
DENTISTRY MODELS
- Bone defect
- Bone regeneration
- Cartilage defect
- Partial/complete ligament rupture
- Synovitis
- Lesión nervio periférico
DIABETES MELLITUS MODELS
- Drug-induced
- Genetics
MALE REPRODUCTIVE APPARATUS MODELS
- Benign Prostatic Hyperplasia
- Prostate cancer
DIGESTIVE MODELS
- Bile duct obstruction
- Colon hyperplasia
VASCULAR MODELS
- Thromboembolism
- Arterial Aneurysms
Strategic partnerships
STUDIES CO-DESIGNED WITH BIOMEDICAL AND TECHNOLOGY INDUSTRY
Transferencia tecnológica, validación clínica y publicaciones conjuntas
Contact us
You can contact us by sending an email to cro@ccmijesususon.com or by using the following form.